Creative Medical Technology Holdings (CELZ) Net Income towards Common Stockholders (2016 - 2025)
Creative Medical Technology Holdings has reported Net Income towards Common Stockholders over the past 16 years, most recently at -$2.2 million for Q4 2025.
- Quarterly Net Income towards Common Stockholders rose 25.09% to -$2.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$6.3 million through Dec 2025, up 4.21% year-over-year, with the annual reading at -$6.3 million for FY2025, 4.21% up from the prior year.
- Net Income towards Common Stockholders was -$2.2 million for Q4 2025 at Creative Medical Technology Holdings, down from -$1.2 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $27.9 million in Q1 2021 and troughed at -$6.2 million in Q4 2022.
- The 5-year median for Net Income towards Common Stockholders is -$1.5 million (2023), against an average of -$458622.6.
- Peak annual rise in Net Income towards Common Stockholders hit 645.22% in 2021, while the deepest fall reached 566.91% in 2021.
- Tracing CELZ's Net Income towards Common Stockholders over 5 years: stood at -$3.9 million in 2021, then plummeted by 60.39% to -$6.2 million in 2022, then soared by 72.99% to -$1.7 million in 2023, then crashed by 77.34% to -$3.0 million in 2024, then grew by 25.09% to -$2.2 million in 2025.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods came in at -$2.2 million, -$1.2 million, and -$1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.